Roundhill Investments - G... (OZEM)
NASDAQ: OZEM
· Real-Time Price · USD
26.26
0.07 (0.27%)
At close: Sep 05, 2025, 3:58 PM
26.00
-0.99%
After-hours: Sep 05, 2025, 06:27 PM EDT
0.27% (1D)
| Bid | 26 |
| Market Cap | 31.86M |
| AUM | 34.72M |
| NAV | 26.3 |
| EPS (ttm) | 1.12 |
| PE Ratio (ttm) | 23.35 |
| Shares Out | 1.21M |
| Inception Date | May 21, 2024 |
| Ask | 26.6 |
| Volume | 3.21K |
| Open | 26.32 |
| Previous Close | 26.19 |
| Day's Range | 26.00 - 26.32 |
| 52-Week Range | 20.01 - 29.21 |
| Holdings | 29 |
| Expense Ratio | 0.59% |
About OZEM
Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Asset Class Equity
Ticker Symbol OZEM
Inception Date May 21, 2024
Provider Other
Website Fund Home Page
Exchange NASDAQ
Top 10 Holdings 61.94% of assets
| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/s | NVO | 18.76% |
| Eli Lilly And Compan... | LLY | 15.64% |
| Structure Therapeuti... | GPCR | 4.94% |
| Metsera, Inc. | MTSR | 4.19% |
| Pfizer Inc. | PFE | 3.76% |
| Astrazeneca PLC | AZN | 3.36% |
| Amgen Inc. | AMGN | 3.10% |
| Viking Therapeutics,... | VKTX | 2.93% |
| Terns Pharmaceutical... | TERN | 2.89% |
| Regeneron Pharmaceut... | REGN | 2.37% |
Dividends Dividend Yield 0.22%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
